← Back to Search resultsInvestor profile:
Investor profile:
ARCH Venture Partners

Address:Chicago, Illinois, United States
Country:
ARCH Venture Partners invests across 14 industries
Most active sector: Biotechnology (43 deals, ~25% of tracked deals)
Disclosed volume in Biotechnology: ~4.5B, typical ticket ~103.6M
Also active in: Pharmaceutical, Medical Research & Treatment, Healthcare, Organization & Employee Experience
Top 5 sectors shown based on public deals · Full sector breakdown is available in the dashboard for Startup and Professional plans.
Tags:
ARCH is an early-stage venture firm focused on life science discoveries to prevent, detect and cure disease.
Deals total173
As lead investor339Also as a second investor: 11
As a second investor75
December 4, 2025USD 78mLead investor
December 4, 2025
USD 78m
Paradigm Health Raises $78M in Series B Funding
Company site
Lead investor
Paradigm Health Raises $78M in Series B Funding
Company site
November 20, 2025USD 115mLead investor
November 20, 2025
USD 115m
Aspen Neuroscience Raises $115M in Series C Funding
Company site
Lead investor
Aspen Neuroscience Raises $115M in Series C Funding
Company site
November 13, 2025USD 65mLead investor
November 13, 2025
USD 65m
Gate Bioscience Raises $65M in Series B Financing
Company site
Lead investor
Gate Bioscience Raises $65M in Series B Financing
Company site
November 6, 2025USD 40mLead investor
November 6, 2025
USD 40m
Elephas Biosciences Raises $40M in Series B-2 Funding
Company site
Lead investor
Elephas Biosciences Raises $40M in Series B-2 Funding
Company site
October 15, 2025
October 15, 2025